scholarly journals Pharmacy services in the emergency department: not a butterfly effect

2019 ◽  
Vol 49 (2) ◽  
pp. 103-104 ◽  
Author(s):  
Chris Alderman
Author(s):  
Souheila N Hachem ◽  
Julie M Thomson ◽  
Melissa K Heigham ◽  
Nancy C MacDonald

Abstract Disclaimer In an effort to expedite the publication of articles related to the COVID-19 pandemic, AJHP is posting these manuscripts online as soon as possible after acceptance. Accepted manuscripts have been peer-reviewed and copyedited, but are posted online before technical formatting and author proofing. These manuscripts are not the final version of record and will be replaced with the final article (formatted per AJHP style and proofed by the authors) at a later time. Purpose The American Society of Health-System Pharmacists (ASHP) and Pediatric Pharmacy Advocacy Group (PPAG) guidelines for providing pediatric pharmacy services in hospitals and health systems can be used to improve medication safety wherever pediatric patients receive care, including in the emergency department (ED). The purpose of this initiative was to improve compliance with these guidelines in a primarily adult ED. Methods This quality improvement initiative was conducted in a level 1 trauma center ED between October 2019 and March 2020. The ASHP-PPAG guidelines were used to create practice elements applicable to the ED. An initial compliance assessment defined elements as noncompliant, partially compliant, fully compliant, or not applicable. Investigators identified interventions to improve compliance for noncompliant or partially compliant elements and then reassessed compliance following implementation. Data were expressed using descriptive statistics. This initiative was exempt from institutional review board approval. Results Ninety-three ED practice elements were identified within the 9 standards of the ASHP-PPAG guidelines. At the initial compliance assessment, the majority (59.8%) of practice elements were fully compliant; however, various service gaps were identified in 8 of the standards, and 16 interventions were implemented to improve compliance. At the final compliance assessment, there was a 19.5% increase in full compliance. Barriers to achieving full compliance included technology restrictions, time constraints, financial limitations, and influences external to pharmacy. Conclusion This quality improvement initiative demonstrated that the ASHP-PPAG guidelines can be used to improve ED pediatric pharmacy services in a primarily adult institution. The initiative may serve as an example for other hospitals to improve compliance with the guidelines.


2018 ◽  
Vol 36 (10) ◽  
pp. 1727-1732 ◽  
Author(s):  
Sofie Rahman Morgan ◽  
Nicole M. Acquisto ◽  
Zlatan Coralic ◽  
Vicki Basalyga ◽  
Matthew Campbell ◽  
...  

1997 ◽  
Vol 54 (15) ◽  
pp. 1702-1705 ◽  
Author(s):  
Dwayne K. Ammons ◽  
Neal Roberts

2010 ◽  
Vol 67 (13) ◽  
pp. 1053-1057 ◽  
Author(s):  
Darrel W. Hughes ◽  
Jennifer M. Roth ◽  
Yolanda Laurel

2010 ◽  
Vol 67 (5) ◽  
pp. 375-379 ◽  
Author(s):  
Joanne C. Witsil ◽  
Roshanak Aazami ◽  
Umbreen Idrees Murtaza ◽  
Daniel P. Hays ◽  
Rollin J. Fairbanks

2004 ◽  
Vol 61 (9) ◽  
pp. 934-937 ◽  
Author(s):  
Rollin J. Fairbanks ◽  
Daniel P. Hays ◽  
David F. Webster ◽  
Linda L. Spillane

2021 ◽  
Author(s):  
D Greenwood ◽  
MP Tully ◽  
S Martin ◽  
D Steinke

Abstract Background: Many countries, including the United Kingdom, have established Emergency Department (ED) pharmacy services where some ED pharmacists now work as practitioners. They provide both traditional pharmaceutical care and novel practitioner care i.e. clinical examination, yet their impact on quality of care is unknown.Aim: To develop a framework of structures, processes and potential outcome indicators to support evaluation of the quality of ED pharmacy services in future studies.Method: Framework components (structures, processes and potential outcome indicators) were identified in three ways, from a narrative review of relevant international literature identified through systematic searches; a panel meeting with ED pharmacists; and a panel meeting with other ED healthcare professionals. Structures and processes were collated into categories developed iteratively throughout data collection, with outcome indicators collated into six domains of quality as proposed by the Institute of Medicine. These raw data were then processed e.g. outcome indicators screened for clarity i.e. those which explicitly stated what would be measured were included in the framework.Results: A total of 190 structures, 533 processes, and 503 outcome indicators were identified. Through data processing a total of 153 outcome indicators were included in the final framework divided into the domains safe (32 outcome indicators), effective (50), patient centred (18), timely (24), efficient (20) and equitable (9). Fewer potential outcome indicators were identified for the patient centred, efficient and equitable domains than others. Conclusion: Whilst frameworks to support evaluation of general ED care exist, this is the first framework specific to ED pharmacy services. Although included in the framework, potential outcome indicators require further development prior to their use in evaluation studies. To that end, evaluation teams should be multidisciplinary and ideally involve researchers with expertise in outcome measurement. Finally, evaluation should not neglect some domains of quality at the expense of others, as previously found by the Institute of Medicine. High quality health services are not only safe, effective and timely, but also patient centred, efficient and equitable.


2003 ◽  
Vol 60 (15) ◽  
pp. 1561-1564 ◽  
Author(s):  
Keith B. Thomasset ◽  
Richard Faris

Sign in / Sign up

Export Citation Format

Share Document